Nkala B - Search Results

1

Novel strategies implemented to ensure high participant retention rates in a community based HIV prevention effectiveness trial in South Africa and Zimbabwe.

Gappoo S, Montgomery ET, Gerdts C, Naidoo S, Chidanyika A, Nkala B, Ramjee G; MIRA Team. Gappoo S, et al. Among authors: nkala b. Contemp Clin Trials. 2009 Sep;30(5):411-8. doi: 10.1016/j.cct.2009.05.002. Epub 2009 May 28. Contemp Clin Trials. 2009. PMID: 19481617 Clinical Trial.

2

Establishing a continuum of care between HIV prevention trials and public healthcare systems: the MIRA Standard of Care program.

Clouse K, Montgomery ET, Milford C, Watadzaushe C, Nkala B, Fancher H, Lince N, Cheng H, Thompson M, van der Straten A. Clouse K, et al. Among authors: nkala b. Clin Trials. 2010 Jun;7(3):256-64. doi: 10.1177/1740774510368299. Epub 2010 Apr 26. Clin Trials. 2010. PMID: 20421242

3

A qualitative study of obstacles to diaphragm and condom use in an HIV prevention trial in sub-Saharan Africa.

Kacanek D, Dennis A, Sahin-Hodoglugil NN, Montgomery ET, Morar N, Mtetwa S, Nkala B, Phillip J, Watadzaushe C, van der Straten A; Mira Team. Kacanek D, et al. Among authors: nkala b. AIDS Educ Prev. 2012 Feb;24(1):54-67. doi: 10.1521/aeap.2012.24.1.54. AIDS Educ Prev. 2012. PMID: 22339145

4

Divergent adherence estimates with pharmacokinetic and behavioural measures in the MTN-003 (VOICE) study.

van der Straten A, Brown ER, Marrazzo JM, Chirenje MZ, Liu K, Gomez K, Marzinke MA, Piper JM, Hendrix CW; MTN-003 VOICE Protocol Team for Microbicide Trials Network. van der Straten A, et al. J Int AIDS Soc. 2016 Feb 4;19(1):20642. doi: 10.7448/IAS.19.1.20642. eCollection 2016. J Int AIDS Soc. 2016. PMID: 26850270 Free PMC article. Clinical Trial.

5

Does participation in an HIV vaccine efficacy trial affect risk behaviour in South Africa?

Gray GE, Metch B, Churchyard G, Mlisana K, Nchabeleng M, Allen M, Moodie Z, Kublin J, Bekker LG; HVTN 503 team. Gray GE, et al. Vaccine. 2013 Apr 12;31(16):2089-96. doi: 10.1016/j.vaccine.2013.01.031. Epub 2013 Jan 29. Vaccine. 2013. PMID: 23370155 Free PMC article.

6

Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase 3, randomised, double-blind, placebo-controlled trial.

Delany-Moretlwe S, Lombard C, Baron D, Bekker LG, Nkala B, Ahmed K, Sebe M, Brumskine W, Nchabeleng M, Palanee-Philips T, Ntshangase J, Sibiya S, Smith E, Panchia R, Myer L, Schwartz JL, Marzinke M, Morris L, Brown ER, Doncel GF, Gray G, Rees H. Delany-Moretlwe S, et al. Among authors: nkala b. Lancet Infect Dis. 2018 Nov;18(11):1241-1250. doi: 10.1016/S1473-3099(18)30428-6. Epub 2018 Oct 24. Lancet Infect Dis. 2018. PMID: 30507409 Clinical Trial.

7

Predictors of parent-adolescent communication in post-apartheid South Africa: a protective factor in adolescent sexual and reproductive health.

Coetzee J, Dietrich J, Otwombe K, Nkala B, Khunwane M, van der Watt M, Sikkema KJ, Gray GE. Coetzee J, et al. Among authors: nkala b. J Adolesc. 2014 Apr;37(3):313-24. doi: 10.1016/j.adolescence.2014.01.006. Epub 2014 Mar 5. J Adolesc. 2014. PMID: 24636691 Free PMC article.

8

Prevalence, type, and correlates of trauma exposure among adolescent men and women in Soweto, South Africa: implications for HIV prevention.

Closson K, Dietrich JJ, Nkala B, Musuku A, Cui Z, Chia J, Gray G, Lachowsky NJ, Hogg RS, Miller CL, Kaida A. Closson K, et al. Among authors: nkala b. BMC Public Health. 2016 Nov 25;16(1):1191. doi: 10.1186/s12889-016-3832-0. BMC Public Health. 2016. PMID: 27884181 Free PMC article.

9

Gender differences in prevalence and correlates of high sexual self-efficacy among adolescents in Soweto, South Africa: implications for gender-sensitive research and programming.

Closson K, Dietrich J, Lachowsky NJ, Nkala B, Cui Z, Chia J, Hogg RS, Gray G, Kaida A, Miller CL. Closson K, et al. Among authors: nkala b. AIDS Care. 2018 Apr;30(4):435-443. doi: 10.1080/09540121.2017.1391983. Epub 2017 Oct 23. AIDS Care. 2018. PMID: 29058527

10

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study.

Gray GE, Allen M, Moodie Z, Churchyard G, Bekker LG, Nchabeleng M, Mlisana K, Metch B, de Bruyn G, Latka MH, Roux S, Mathebula M, Naicker N, Ducar C, Carter DK, Puren A, Eaton N, McElrath MJ, Robertson M, Corey L, Kublin JG; HVTN 503/Phambili study team. Gray GE, et al. Lancet Infect Dis. 2011 Jul;11(7):507-15. doi: 10.1016/S1473-3099(11)70098-6. Epub 2011 May 11. Lancet Infect Dis. 2011. PMID: 21570355 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page